Chromosome abnormalities in secondary myelodysplastic syndromes.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007621:Karyotyping; D007938:Leukemia / Q000139:chemically induced / Q000235:genetics*; D007953:Leukemia, Radiation-Induced; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000209:etiology / Q000235:genetics*; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents